$5.01
-0.06[-1.18%]
At close: May 17
$5.01
0[0.00%]
After Hours: 4:00PM EDT
uniQure
(NASDAQ:QURE)uniQure Stock (NASDAQ:QURE), Analyst Ratings, Price Targets, Predictions
uniQure NV has a consensus price target of $38.13, established from looking at the 39 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Mizuho, and Mizuho on May 8, 2024, May 8, 2024, and March 4, 2024. With an average price target of $12.67 between HC Wainwright & Co., Mizuho, and Mizuho, there's an implied 152.83% upside for uniQure NV from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Mizuho
Goldman Sachs
RBC Capital
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for uniQure
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | Buy Now | 399% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | 19.76% | Mizuho | Uy Ear | $7 → $6 | Maintains | Neutral | Get Alert |
| 03/04/2024 | Buy Now | 39.72% | Mizuho | Uy Ear | $10 → $7 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 399% | HC Wainwright & Co. | Patrick Trucchio | $30 → $25 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 59.68% | Goldman Sachs | Salveen Richter | $63 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 01/19/2024 | Buy Now | 498.8% | HC Wainwright & Co. | Patrick Trucchio | → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | 458.88% | RBC Capital | Luca Issi | → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 12/20/2023 | Buy Now | 319.16% | Cantor Fitzgerald | Kristen Kluska | → $21 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | Buy Now | 99.6% | Mizuho | Uy Ear | → $10 | Downgrade | Buy → Neutral | Get Alert |
| 11/08/2023 | Buy Now | 1157.49% | Goldman Sachs | Salveen Richter | $56 → $63 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 498.8% | HC Wainwright & Co. | Patrick Trucchio | $90 → $30 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 738.32% | RBC Capital | Luca Issi | $47 → $42 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | 898% | Raymond James | Danielle Brill | $56 → $50 | Maintains | Outperform | Get Alert |
| 06/22/2023 | Buy Now | 438.92% | Chardan Capital | Matthew Barcus | $45 → $27 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 1696.41% | HC Wainwright & Co. | Patrick Trucchio | → $90 | Reiterates | Buy → Buy | Get Alert |
| 05/19/2023 | Buy Now | 738.32% | UBS | Eliana Merle | $45 → $42 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | 798.2% | Chardan Capital | Matthew Barcus | $56 → $45 | Maintains | Buy | Get Alert |
| 05/16/2023 | Buy Now | 1017.76% | Raymond James | Danielle Brill | $58 → $56 | Maintains | Outperform | Get Alert |
| 05/11/2023 | Buy Now | 997.8% | Truist Securities | Robyn Karnauskas | $65 → $55 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 957.88% | RBC Capital | Luca Issi | → $53 | Reiterates | → Outperform | Get Alert |
| 03/07/2023 | Buy Now | 1696.41% | HC Wainwright & Co. | Patrick Trucchio | → $90 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | 957.88% | Guggenheim | Debjit Chattopadhyay | → $53 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | 997.8% | Credit Suisse | Judah Frommer | $51 → $55 | Maintains | Outperform | Get Alert |
| 02/28/2023 | Buy Now | 1097.6% | Chardan Capital | Matthew Barcus | → $60 | Reiterates | → Buy | Get Alert |
| 11/23/2022 | Buy Now | 738.32% | UBS | Eliana Merle | $40 → $42 | Maintains | Buy | Get Alert |
| 11/23/2022 | Buy Now | 1037.72% | Goldman Sachs | Salveen Richter | $47 → $57 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | 858.08% | Goldman Sachs | Julien Richer | $54 → $48 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 379.04% | Wells Fargo | Yanan Zhu | $34 → $24 | Maintains | Equal-Weight | Get Alert |
| 08/09/2022 | Buy Now | 1097.6% | Chardan Capital | Matthew Barcus | $65 → $60 | Maintains | Buy | Get Alert |
| 05/24/2022 | Buy Now | 917.96% | Goldman Sachs | Salveen Richter | $59 → $51 | Maintains | Buy | Get Alert |
FAQ
What is the target price for uniQure (QURE)?
The latest price target for uniQure (NASDAQ: QURE) was reported by HC Wainwright & Co. on May 8, 2024. The analyst firm set a price target for $25.00 expecting QURE to rise to within 12 months (a possible 399.00% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for uniQure (QURE)?
The latest analyst rating for uniQure (NASDAQ: QURE) was provided by HC Wainwright & Co., and uniQure reiterated their buy rating.
When was the last upgrade for uniQure (QURE)?
The last upgrade for uniQure NV happened on March 17, 2022 when UBS raised their price target to $40. UBS previously had a neutral for uniQure NV.
When was the last downgrade for uniQure (QURE)?
The last downgrade for uniQure NV happened on February 29, 2024 when Goldman Sachs changed their price target from $63 to $8 for uniQure NV.
When is the next analyst rating going to be posted or updated for uniQure (QURE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of uniQure, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for uniQure was filed on May 8, 2024 so you should expect the next rating to be made available sometime around May 8, 2025.
Is the Analyst Rating uniQure (QURE) correct?
While ratings are subjective and will change, the latest uniQure (QURE) rating was a reiterated with a price target of $0.00 to $25.00. The current price uniQure (QURE) is trading at is $5.01, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.